Improving Document Review Practices in Pharmaceutical Companies

Stephen A. Bernhardt

14 citations0/0 files storedJournal of Business and Technical Communication

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Academic Writing and Publishing Publishing and Scholarly Communication Software Engineering Techniques and Practices

Abstract

Document review practices in the research and development functions of many pharmaceutical companies can be frustrating and inefficient, at least in part because these practices are poorly managed. Although the literature on review practice is fairly robust, there is a disjuncture between what researchers know and how reviewers work. The author draws on his experience as a consultant and trainer to many pharmaceutical companies to outline the causes and effects of poor review practice. He offers recommendations to enhance the value and increase the efficiency of reviews.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 14 citations exist upstream.

References

1994Situated Learning: Legitimate Peripheral Participation.1991Situated Learning 1994Handbook of Qualitative Research 2008Participatory Action Research 2001The Myth of the Paperless Office 1994Writing in the Workplace: New Research Perspectives 1995No More Teams!: Mastering the Dynamics of Creative Collaboration 1994Managing your documentation projects

Cited by

2012Missed Opportunities in the Review and Revision of Clinical Study Reports

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

Imported from OpenAlex (CC0) — nothing here is generated.